PHARMACEUTICAL 6,5 HETEROBICYCLIC RING DERIVATIVES
The invention relates to 6,5 heterobicyclic ring derivatives, processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as SLE and geographic atrophy.
-
Paragraph 0165-0166
(2019/09/01)
More Articles about upstream products of 1342811-51-1